Researchers have developed a new way to determine whether individual patients will respond to a specific cancer drug or not. This kind of test could help doctors to choose alternative therapies for patients who don't respond to the therapies normally used to treat their cancer.
source https://www.sciencedaily.com/releases/2021/10/211006112725.htm
Thursday, 7 October 2021
Related Posts
Creating a new 'toehold' for RNA therapeutics, cell therapies, and diagnosticsSynthetic biologists have developed eToeholds -- small versatile devic… Read More
Brain connectivity is lower in adults with PTSD or a history of sexual abuseA study has found that adults with maltreatment-related posttraumatic … Read More
Engineers devise a way to selectively turn on RNA therapies in human cellsResearchers have designed a way to selectively turn on gene expression… Read More
New computer modeling could boost drug discoveryScientists have developed a computer-aided data tool that could improv… Read More
Powerful X-ray technique finds new degradation-inducing materials in British shipwreckIn 1545, King Henry VIII's favorite ship, the Mary Rose, capsized and … Read More
Long-lived proteins in mitochondria of brain stabilize protein complexesScientists have taken a closer look at how mitochondria are maintained… Read More
0 comments: